Fmoc-Gly-Thr(Psi(Me,Me)pro)-OH

Fmoc-Gly-Thr(Psi(Me,Me)pro)-OH is a protected dipeptide building block in which glycine is N-Fmoc-protected and threonine is incorporated as a side-chain-modified amino acid bearing a Psi(Me,Me)pro substituent (a proline-like constrained motif). The molecule contains a peptide-grade amide linkage, a free carboxylic acid for downstream coupling, and an Fmoc carbamate that enables standard base-labile N-deprotection during solid-phase peptide synthesis. The threonine stereocenter and the Psi(Me,Me)pro side-chain constraint introduce defined three-dimensional geometry that can influence backbone conformation and protease/peptidase recognition patterns in peptidomimetic design. The presence of a single reactive C-terminal acid paired with an orthogonally removable N-protecting group supports controlled peptide elongation and selective derivatization workflows in both research and process-oriented synthesis.

1. Peptide Synthesis

Fmoc-Gly-Thr(Psi(Me,Me)pro)-OH supports peptide building and library synthesis in solid-phase peptide chemistry where the Fmoc group enables stepwise N-terminal deprotection and re-coupling. The glycine residue provides a canonical amide-forming handle, while the threonine-derived side-chain constraint can be carried through as a stable stereodefined unit during chain assembly. The free C-terminal carboxylic acid participates in peptide coupling chemistry to form new amide bonds under standard protected-amino-acid strategies, allowing incorporation into longer sequences that probe conformational effects. The resulting peptidomimetic peptides can be used as research-grade substrates for evaluating sequence-dependent behavior and as intermediates for further functional group installation at other positions.

2. Peptidomimetics And SAR

Fmoc-Gly-Thr(Psi(Me,Me)pro)-OH is suitable for structure-activity relationship studies and peptidomimetic construction where constrained threonine side-chain geometry can modulate local hydrogen-bonding patterns and backbone preferences. The Psi(Me,Me)pro motif, together with the defined threonine stereochemistry, can be leveraged to generate analog series that compare unconstrained versus constrained side-chain architectures. The N-Fmoc-protected glycine and the C-terminal acid enable rapid substitution into different peptide scaffolds, supporting systematic variation of neighboring residues while maintaining the same stereochemical element. The produced analogs can then serve as chemically defined reference materials for SAR mapping, fragment-to-lead optimization, and conformational hypothesis testing in medicinal chemistry workflows.

3. Chemical Biology Probes

Fmoc-Gly-Thr(Psi(Me,Me)pro)-OH can be applied in chemical biology research for generating defined peptide probes that incorporate a constrained threonine analog for controlled recognition. The peptide backbone functionality and the orthogonal protection scheme allow the building block to be inserted into affinity tags, activity-based probe scaffolds, or labeled peptide conjugates where site-specific coupling is required. The Fmoc group supports clean deprotection cycles, while the C-terminal carboxylic acid can be used as a handle for downstream conjugation strategies after peptide assembly. The resulting constrained peptides may serve as reagents for studying substrate selectivity, binding-site tolerance to side-chain modifications, and mechanistic behavior of peptide-processing enzymes.

4. Bioconjugation Chemistry

Fmoc-Gly-Thr(Psi(Me,Me)pro)-OH is relevant to bioconjugation workflows that require peptide-derived linkers with stereochemically defined motifs. The protected amine and carboxylic acid functionality enable its use as a controlled intermediate for preparing peptide segments that can be coupled to biomolecule-reactive partners after chain assembly. The constrained Psi(Me,Me)pro side chain can influence solubility, conformational rigidity, and presentation of amide NH and carbonyl groups, which can affect how conjugates behave in labeling or binding assays. The building block can therefore be employed to generate chemically defined conjugation precursors for downstream attachment to proteins, polymers, or surfaces while preserving the intended stereochemical architecture.

5. Process Chemistry Intermediate

Fmoc-Gly-Thr(Psi(Me,Me)pro)-OH functions as a manufacturable peptide intermediate for process chemistry and fine chemical synthesis where standardized protection and coupling logic improves route design. The Fmoc carbamate provides a predictable base-labile deprotection step, and the C-terminal carboxylic acid is compatible with common peptide coupling activation strategies used in industrial peptide manufacturing. The stereochemically defined threonine and the Psi(Me,Me)pro side-chain constraint reduce ambiguity in structural identity across batches, supporting consistent downstream synthesis of peptidomimetic products. The compound can be utilized to prepare larger peptide intermediates at scale, including penultimate fragments for final assembly, analytical reference standards, or feedstocks for producing constrained peptide materials.

6. Analytical Research Standards

Fmoc-Gly-Thr(Psi(Me,Me)pro)-OH is suitable for analytical research and method development where defined peptide chemistry standards are required for LC-MS, HPLC, and MS/MS characterization. The presence of a single Fmoc-protected N-terminus and a free C-terminal acid yields a reproducible fragmentation pattern once incorporated into peptides or after controlled deprotection during sample preparation. The constrained Psi(Me,Me)pro motif and threonine stereochemistry can help distinguish target-containing sequences from closely related unconstrained analogs during method qualification. The compound can therefore serve as a chemically characterized intermediate for calibration, impurity profiling, and identity confirmation in workflows that track protected amino acid derivatives and assembled peptidomimetics.

1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

2. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. Myotropic activity of allatostatins in tenebrionid beetles

5. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L